Hematology & Oncology Doctors in New Braunfels, TX Accepting Medicare

3 Hematology & Oncology doctors found. Showing 1 - 3

Christopher David Braden, D.O. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1448 E Common St, New Braunfels, TX 78130 Phone: 830-643-1762    Fax: 830-609-7702

Alexander S Zweibach, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1448 E Common St, New Braunfels, TX 78130 Phone: 830-643-1762    Fax: 830-609-7702

Albert J. Wood, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 524 Enchanted Oak, New Braunfels, TX 78132 Phone: 512-787-1031

News Archive

ASPREE study aims to assess health benefits of aspirin

In an effort to extend the length of a disability-free life for older adults, researchers from Rush University Medical Center are partnering with colleagues from across the U.S. and Australia in the largest international trial ever sponsored by the National Institute on Aging.

Envision Conference 2014 kicks off with presentation of two prestigious awards

Envision announced today that Second Sight Medical Products, Inc., a San Fernando Valley, Calif.-based medical device manufacturer, and Janet Sunness, M.D., Medical Director of Richard E. Hoover Low Vision Rehabilitation Services at Greater Baltimore Medical Center in Towson, Md., were named the 2014 recipients, respectively, of the Envision Oculus Award and Envision Award in Low Vision Research, two prestigious honors acknowledging substantial contributions to furthering research and facilitating collaborative efforts toward addressing low vision and the conditions that cause it.

New Vortik technology has potential in pharmaceutical industry

The new Vortik technology allows different liquids to be mixed at the point of spray without altering the spray characteristics – opening up the possibility of new applications in agriculture, consumer and industrial products, and healthcare.

Adding DNA sequencing to newborn screenings may increase early diagnosis of cystic fibrosis

A study by researchers at Children's Hospital Los Angeles, Brigham and Women's Hospital and the California Department of Public Health suggests that all babies with a known mutation for cystic fibrosis (CF) and second mutation called the 5T allele should receive additional screening in order to better predict the risk of developing CF later in life.

Why the GMC is right to appeal over life prolonging treatment

The General Medical Council, Britain's regulatory body for doctors, is right to appeal against a high court ruling that its current guidance on withholding and withdrawing life prolonging treatment is unlawful, says a professor of medical ethics in this week's BMJ.

Read more Medical News

› Verified 8 days ago